Yes. James Inhofe disclosed 3 purchases and 2 sales of Allergan (AGN) stock between Jul 21, 2016 and Feb 22, 2018, in STOCK Act reports. Added together, the disclosed purchases come to $80K-$200K and the disclosed sales to $100K-$200K.
Yes. James Inhofe disclosed 3 purchases and 2 sales of Allergan (AGN) stock between Jul 21, 2016 and Feb 22, 2018, in STOCK Act reports. Added together, the disclosed purchases come to $80K-$200K and the disclosed sales to $100K-$200K.
How big were James Inhofe's Allergan trades?
STOCK Act reports give a range for each trade, such as $50K-$100K, never an exact amount. Added together, the disclosed purchases come to $80K-$200K and the disclosed sales to $100K-$200K.
Did James Inhofe make these Allergan trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does James Inhofe still own Allergan stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did James Inhofe report these trades?
The latest filing is dated Feb 26, 2018. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Reported trades and amount ranges, not what is held today. Reports can include a spouse and dependent children.
Loading